Literature DB >> 22491003

Communicating about phase I trials: objective disclosures are only a first step.

Anne Lederman Flamm, Rebecca D Pentz.   

Abstract

Mesh：

Year:  2012        PMID： 22491003      PMCID： PMC3336836          DOI： 10.1634/theoncologist.2012-0107

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  27 in total

1.  Arrogance ignorance paradox.

Authors:  Charles F von Gunten
Journal:  J Palliat Med       Date:  2005-10       Impact factor: 2.947

2.  Improving physician-patient communication in cancer care: outcome of a workshop for oncologists.

Authors:  W F Baile; R Lenzi; A P Kudelka; P Maguire; D Novack; M Goldstein; E G Myers; R C Bast
Journal:  J Cancer Educ       Date:  1997       Impact factor: 2.037

3.  A phase I trial on the ethics of phase I trials.

Authors:  E J Emanuel
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

4.  Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective.

Authors:  C K Daugherty
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

5.  Searching for a way to live to the end: decision-making process in patients considering participation in cancer phase I clinical trials.

Authors:  Izumi Kohara; Tomoko Inoue
Journal:  Oncol Nurs Forum       Date:  2010-03       Impact factor: 2.172

Review 6.  Patient-physician communication in oncology: past, present, and future.

Authors:  Walter F Baile; Joann Aaron
Journal:  Curr Opin Oncol       Date:  2005-07       Impact factor: 3.645

7.  Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials.

Authors:  Thomas G Roberts; Bernardo H Goulart; Lee Squitieri; Sarah C Stallings; Elkan F Halpern; Bruce A Chabner; G Scott Gazelle; Stan N Finkelstein; Jeffrey W Clark
Journal:  JAMA       Date:  2004-11-03       Impact factor: 56.272

8.  Communication skills training in oncology. Description and preliminary outcomes of workshops on breaking bad news and managing patient reactions to illness.

Authors:  W F Baile; A P Kudelka; E A Beale; G A Glober; E G Myers; A J Greisinger; R C Bast; M G Goldstein; D Novack; R Lenzi
Journal:  Cancer       Date:  1999-09-01       Impact factor: 6.860

9.  Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consent.

Authors:  Kevin P Weinfurt; Damon M Seils; Janice P Tzeng; Kate L Compton; Daniel P Sulmasy; Alan B Astrow; Nicholas A Solarino; Kevin A Schulman; Neal J Meropol
Journal:  Med Decis Making       Date:  2008-03-31       Impact factor: 2.583

10.  Perceptions of cancer patients and their physicians involved in phase I trials.

Authors:  C Daugherty; M J Ratain; E Grochowski; C Stocking; E Kodish; R Mick; M Siegler
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544
View more
  1 in total

1.  American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.

Authors:  Jeffrey S Weber; Laura A Levit; Peter C Adamson; Suanna Bruinooge; Howard A Burris; Michael A Carducci; Adam P Dicker; Mithat Gönen; Stephen M Keefe; Michael A Postow; Michael A Thompson; David M Waterhouse; Susan L Weiner; Lynn M Schuchter
Journal:  J Clin Oncol       Date:  2014-12-15       Impact factor: 44.544
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.